Synopsys (NASDAQ:SNPS) Stock: Insider Sudhindra Kankanwadi Sells 3,000 Shares

Key Points

  • CFO Sudhindra Kankanwadi sold 9,170 Synopsys shares for approximately $4.59 million at an average price of $500, reducing his position by 28.76%. He had also sold 3,000 shares the previous day.
  • Synopsys reported quarterly results above expectations, with earnings of $3.91 per share and revenue of $2.48 billion, up 42.4% year over year. The stock opened at $505.17 and has a consensus analyst rating of “Moderate Buy” with a $584.11 price target.
  • The board approved a $1 billion share-repurchase program, allowing the company to buy back up to 1.1% of its outstanding shares, while new AI-related alliances with OpenAI and Amazon support the company’s growth outlook.

Synopsys, Inc. (NASDAQ:SNPS - Get Free Report) CFO Sudhindra Kankanwadi sold 3,000 shares of Synopsys stock in a transaction on Monday, October 5th. The stock was sold at an average price of $484.78, for a total value of $1,454,340.00. Following the sale, the chief financial officer directly owned 22,717 shares of the company's stock, valued at approximately $11,012,747.26. This trade represents a 11.67% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Sudhindra Kankanwadi also recently made the following trade(s):

  • On Tuesday, October 6th, Sudhindra Kankanwadi sold 9,170 shares of Synopsys stock. The shares were sold at an average price of $500.00, for a total value of $4,585,000.00.

Synopsys Trading Up 3.4%

NASDAQ:SNPS opened at $505.17 on Wednesday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. Synopsys, Inc. has a 1-year low of $362.55 and a 1-year high of $539.48. The firm has a market capitalization of $96.81 billion, a price-to-earnings ratio of 89.25, a PEG ratio of 1.99 and a beta of 1.21. The business's 50-day moving average price is $412.43 and its two-hundred day moving average price is $437.43.




Synopsys (NASDAQ:SNPS - Get Free Report) last posted its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.67 by $0.24. The company had revenue of $2.48 billion during the quarter, compared to analyst estimates of $2.44 billion. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The company's revenue for the quarter was up 42.4% compared to the same quarter last year. During the same period in the previous year, the company earned $3.39 EPS. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. On average, equities analysts expect that Synopsys, Inc. will post 10.97 earnings per share for the current year.

Synopsys declared that its Board of Directors has initiated a share buyback plan on Monday, October 5th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the semiconductor company to reacquire up to 1.1% of its stock through open market purchases. Stock buyback plans are typically an indication that the company's board believes its shares are undervalued.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on SNPS. HSBC cut shares of Synopsys from a "buy" rating to a "reduce" rating in a research report on Friday, September 25th. Robert W. Baird upgraded shares of Synopsys from a "neutral" rating to an "outperform" rating and upped their price objective for the company from $558.00 to $560.00 in a research report on Thursday, August 27th. Needham & Company LLC reaffirmed a "buy" rating and set a $580.00 price objective on shares of Synopsys in a research note on Thursday, August 27th. Zacks Research upgraded Synopsys from a "hold" rating to a "strong-buy" rating in a report on Friday, October 2nd. Finally, Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a $640.00 target price on shares of Synopsys in a research note on Thursday, October 1st. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $584.11.

View Our Latest Research Report on Synopsys

Institutional Investors Weigh In On Synopsys

A number of hedge funds and other institutional investors have recently bought and sold shares of SNPS. Sankala Group LLC bought a new position in shares of Synopsys during the 4th quarter worth approximately $25,000. Elevation Wealth Partners LLC lifted its position in shares of Synopsys by 96.4% in the second quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock worth $25,000 after purchasing an additional 27 shares in the last quarter. Osbon Capital Management LLC acquired a new position in Synopsys during the second quarter worth $25,000. IMG Wealth Management Inc. acquired a new position in Synopsys during the second quarter worth $28,000. Finally, Phillip James Consulting Co. bought a new position in Synopsys in the fourth quarter valued at $36,000. Institutional investors and hedge funds own 85.47% of the company's stock.

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys announced new AI chip-design alliances with OpenAI and Amazon, reinforcing its position as a supplier of electronic-design-automation tools for the growing AI infrastructure market. The expanded Amazon relationship is described as a potential $1 billion catalyst. Synopsys Is Up 17.7% After New AI Chip-Design Alliances With OpenAI And Amazon
  • Positive Sentiment: Synopsys initiated an accelerated share-repurchase agreement with JPMorgan to buy back approximately $1 billion of stock, equal to as much as 1.1% of outstanding shares. The program may support earnings per share and signals management’s confidence in the company’s long-term value. Synopsys Initiates $1 Billion Accelerated Share Repurchase Agreement
  • Neutral Sentiment: A valuation comparison with Progress Software examines whether SNPS offers better value among computer-software stocks. The discussion is relevant because Synopsys has strong AI-growth exposure, but investors must weigh that opportunity against its premium valuation. PRGS vs. SNPS: Which Stock Should Value Investors Buy Now?
  • Negative Sentiment: Despite beating earnings estimates three times this year, Synopsys has reportedly seen its shares decline after each earnings release. The recurring pattern suggests investors may continue to sell the stock on strong results if expectations are already high. Synopsys is Hot Again But a Pattern Has Emerged

Synopsys Company Profile

(Get Free Report)

Synopsys, Inc is a technology company that develops electronic design automation (EDA) software, semiconductor intellectual property (IP), and software tools used to design, verify, and manufacture advanced electronic systems. Its solutions support the development of semiconductors, systems-on-chip, and electronic products across the design cycle, from initial specification and architecture through testing and production.

The company's offerings include digital and custom integrated-circuit design tools, simulation and verification software, physical design and signoff products, and semiconductor IP such as processor cores, interface technologies, and foundational components.

Further Reading

Insider Buying and Selling by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Synopsys?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Synopsys and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles